Cache DNA

Cache DNA is an early-stage biotech company pioneering ambient-temperature storage solutions for nucleic acids and biomolecules. Founded in 2021 as an MIT spinout, the company is developing a proprietary 'ensilication' technology that encapsulates biomolecules in a protective glassy polymer matrix, eliminating the need for freezers. This innovation addresses critical bottlenecks in biobanking and clinical research by reducing costs, simplifying logistics, and preserving sample quality for emerging long-read sequencing and multi-omics applications. Backed by scientific luminaries and competitive grants, Cache is positioning itself as a key enabler for the future of scalable genomic medicine.

Ambient-temperature biopreservation via 'ensilication' technology, which encapsulates nucleic acids in a reversible, protective glassy polymer matrix for long-term storage without refrigeration.

Cache competes with traditional cold-storage solutions (freezers, ultra-cold freezers) and companies offering stabilized sample collection cards (e.g., Whatman FTA cards). Its differentiation lies in aiming to preserve high-molecular-weight native DNA/RNA for advanced sequencing, a claim beyond most ambient methods. Potential future competitors include large biobanking suppliers (e.g., Azenta, Brooks) and startups in DNA data storage.